Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study reports benefits of aspirin plus Plavix

This article was originally published in The Tan Sheet

Executive Summary

A study shows patients with atrial fibrillation reduced their risk of major vascular events by 11 percent by taking Plavix (clopidogrel) plus aspirin compared to aspirin alone. The results "suggest a potential change in clinical practice," says a study investigator. Findings announced March 31 from the ACTIVE A (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Cardiovascular Events) phase III double-blind, placebo-controlled trial also said the heart arrhythmia patients taking the antiplatelet drug and aspirin saw a 28 percent reduction in stroke during the median 3.6 years of follow-up. Bristol-Myers Squibb and Sanofi-Aventis, which jointly market Plavix, sponsored the study. Atrial fibrillation patients have a five-fold greater stroke risk and cannot take oral anticoagulants, a researcher said. A 2007 analysis found aspirin alone is more effective than Plavix and other Rx antiplatelets in preventing first or repeat heart attack or stroke (1"The Tan Sheet" April 23, 2007, p. 10)
Advertisement

Related Content

Aspirin Tops Three Rx Drugs In Preventing Heart Attack – Consumers Union
Aspirin Tops Three Rx Drugs In Preventing Heart Attack – Consumers Union

Topics

Advertisement
UsernamePublicRestriction

Register

PS102786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel